Recent News

By Category: Biotechnology

FDA Approves Inhalational Anthrax Therapeutic

Emergent BioSolutions Inc. today announced that the U.S. Food and Drug Administration has approved Anthrasil [Anthrax Immune Globulin Intravenous (Human)], also known as AIGIV, for treatment of inhalational anthrax in combination with appropriate antibacterial drugs. Achievement of this milestone triggers a $7 million payment to the company under a development contract with the Biomedical Advanced Read More »

March 26, 2015
| Filed under Biotechnology and Countermeasures
Share

Mutating bird flu, powdered alcohol, physical activity and brain damage

March 16, 2015
| Filed under Biosafety and Biotechnology
Share

Findings of Tulane Biosecurity Breach Investigation

Officials with the Centers for Disease Control and Prevention (CDC), along with the U. S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) have completed their joint investigation into how the Burkholderia pseudomallei bacteria may have been inadvertently transferred from a secure, select agent laboratory into animals from the breeding colony of Read More »

March 16, 2015
| Filed under Biosafety and Biotechnology
Share

NIAID Seeks Biodefense Priority Pathogen Therapeutics

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information regarding efforts to develop therapeutic products that demonstrate activity for the treatment of diseases on the NIAID Category A, B and C Priority Pathogens list.

March 12, 2015
| Filed under Agents & Toxins, Biosafety, and Biotechnology
Share

Effect of Experimental Ebola Vaccine after High-Risk Exposure

A study appearing this week in JAMA analyzes the case of a 44-year-old U.S. physician who received an experimental Ebola vaccine after experiencing a needle stick while working in an Ebola treatment unit in Sierra Leone.